| Date Filed | Type | Description |
| 08/11/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/15/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/16/2022 |
4
| Legorreta Pablo G. (10% Owner) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Unknown transaction of 31,933,334 shares
@ $0
Disposed/sold 8,060 restricted stock units
@ $0
Disposed/sold 8,994 restricted stock units
@ $0 |
|
| 08/10/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/19/2022 |
4
| Legorreta Pablo G. (10% Owner) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 41,006 options to buy
@ $0.56, valued at
$23k
Granted 8,994 restricted stock units
@ $0 |
|
| 05/11/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/01/2022 |
4
| Legorreta Pablo G. (10% Owner) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Bought 22,666,667 shares
@ $1.5, valued at
$34M
|
|
| 11/15/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/12/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 06/15/2021 |
4
| Legorreta Pablo G. (10% Owner) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 40,559 options to buy
@ $8.53, valued at
$346k
Granted 8,060 restricted stock units
@ $0 |
|
| 05/17/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/12/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/12/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/14/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 06/02/2020 |
4
| Legorreta Pablo G. (10% Owner) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 14,103 options to buy
@ $17.55, valued at
$247.5k
|
|
| 05/15/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/13/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/08/2019 |
3
| Legorreta Pablo G. (Director) has filed a Form 3 on Epizyme, Inc. |
| 08/07/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/15/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 04/15/2013 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 04/15/2013 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 04/03/2013 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 03/06/2013 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 03/06/2013 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party |
| 02/25/2013 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party |
| 12/23/2010 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership |